MenuClose

  • JP
  • SearchClose
Home
About JBIC
About JBIC

This page introduces information on JBIC's role and organization.

Close

Support Menu
Support Menu

JBIC offers a range of financial products and other services to our clients.

Close

Business Areas
Business Areas

Information about JBIC's activities in each business area and its efforts for environmental conservation.

Close

Public Information
Public Information

Various reports compiled and contributed by JBIC

Close

Press Releases
Press Releases

Close

Investor Relations
Investor Relations

This page introduces information on JBIC's investor relations.

Close

Loan for Medical Device Manufacturing and Sales Business of JMS Healthcare Phl, Inc., Philippine Subsidiary of JMS Co., Ltd.
Supporting Overseas Business Expansion of Japanese Company

  • Region: Asia
  • Manufacturing and Services
  • Overseas Investment Loans
December 23, 2021
  1. The Japan Bank for International Cooperation (JBIC; Governor: MAEDA Tadashi) signed today a loan agreement amounting to up to approximately USD5 million (JBIC portion) with JMS Healthcare Phl, Inc. (JMSHP), a Philippine subsidiary of JMS Co., Ltd. (JMS). The loan is co-financed with Mizuho Bank, Ltd. and MUFG Bank, Ltd., bringing the total co-financing amount to approximately USD8 million.
      
  2. The loan is intended to finance the funds necessary for JMSHP to conduct the business of manufacturing and sales of medical devices.
      
  3. Since its founding in 1965, JMS has been manufacturing and selling disposable medical devices*1 such as infusion kits and blood bags. The company expanded its business overseas in the 1970s, and its medical devices are currently sold in 90 countries from its eight manufacturing and sales bases, including JMSHP. With the aim of further expanding its global business, JMS is planning to increase its medical device manufacturing lines. The loan will support JMS’s overseas business expansion, thereby contributing toward maintaining and improving the international competitiveness of Japanese industry.
      
  4. By supporting JMSHP in manufacturing medical devices such as infusion kits that help to prevent infections and in supplying the devices to Japan, Europe, the United States, and Southeast Asia through the JMS group companies, the loan is also expected to contribute toward raising the level of health and hygiene in the countries.
      
  5. As Japan’s policy-based financial institution, JBIC will continue to provide financial support to assist Japanese companies in the overseas expansion of their businesses by drawing on its various financial facilities and schemes for structuring projects and by performing its risk-assuming function.
      
Note
  1. *1 
    In the field of medical care, the term “disposable devices” generally refers to “pre-sterilized and immediately usable items that are not reused.”

Search press releases

Fiscal Years
Sectors
Region
Finance Menu